Skip to main content

Newsroom Search

Search the Newsroom

Filter By

Related specialties and programs

Showing 251 - 260 of 2720 results

News Brief

FDA Approves Two Gene Therapies for Sickle Cell Disease

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 

Post

Feature Article: RRPF – “While We Breathe, We Hope”

Recurrent respiratory papillomatosis (RRP) is a disease characterized by the growth of noncancerous tumors around the vocal cords caused by HPV infection. Find out more about RRP and the work of the Recurrent Respiratory Papillomatosis Foundation.

Post

Vaccine News & Notes — December 2023

Find out about Mrs. Carter’s impact on vaccines in the U.S. Check out a study on influenza disease and vaccine in kids. And find out about the Polio Network, a national and international resource for individuals and families affected by polio.

Post

News at CHOP: Fall 2023

Stay up to date on the latest research and staff news from Children’s Hospital of Philadelphia.

Jump back to top